TREATMENT OF VARIOUS FORMS OF MACULOPATHY BASED ON DIAGNOSTIC CRITERIA AND A DIFFENTIAL APPROACH

Authors

  • Kasimov Akhmad Kamaldinovich Doctor of Medical Sciences, Docent Andijan State Medical Institute

Abstract

Maculopathy refers to a collection of retinal disorders that primarily affect the macula, a small yet critical area located in the center of the retina. The macula is responsible for central vision, allowing us to perform tasks requiring detailed vision, such as reading, recognizing faces, and driving. The macula is highly sensitive, containing a high concentration of photoreceptor cells, which are responsible for converting light into electrical signals that are transmitted to the brain for processing. Therefore, any disruption to the macula can significantly affect visual acuity, impairing an individual's ability to engage in everyday activities and potentially leading to blindness if left untreated. The term “maculopathy” encompasses several conditions, but the most common forms are Age-Related Macular Degeneration (AMD), Diabetic Maculopathy, and Macular Edema. These diseases have distinct etiologies, pathophysiological mechanisms, and clinical manifestations, yet they all contribute to a significant loss of central vision, which is critical for normal functioning. Understanding the diagnostic criteria and treatment strategies for each type of maculopathy is vital for managing these diseases and preventing further visual deterioration.

References

Mitchell P., Liew G., Harper C. A., & Wong T. Y. (2018). The Role of Anti-VEGF in the Management of Age-Related Macular Degeneration. Ophthalmology, 125(1), 121-132.

Antoniou M. A., & Mandal G. (2019). Efficacy of Anti-VEGF Injections in Diabetic Macular Edema: A Comprehensive Review. Clinical Ophthalmology, 13, 1961-1970.

Campochiaro P. A., & Bressler N. M. (2017). Retinal Vein Occlusion: Current Concepts and Emerging Therapies. Archives of Ophthalmology, 125(6), 782-790.

Age-Related Eye Disease Study 2 (AREDS2) Research Group (2013). A Randomized Trial of Zinc and Antioxidant Supplements for Age-Related Macular Degeneration and Cataract. JAMA, 310(19), 1925-1933.

Diabetic Retinopathy Clinical Research Network (DRCR.net) (2015). Ranibizumab for Diabetic Macular Edema. New England Journal of Medicine, 372, 102-111.

Published

2025-04-13

How to Cite

Kasimov Akhmad Kamaldinovich. (2025). TREATMENT OF VARIOUS FORMS OF MACULOPATHY BASED ON DIAGNOSTIC CRITERIA AND A DIFFENTIAL APPROACH. Ethiopian International Journal of Multidisciplinary Research, 12(04), 209–212. Retrieved from https://www.eijmr.org/index.php/eijmr/article/view/2880